Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: Findings from the Netherlands Mental Health Survey and Incidence Study

被引:283
|
作者
de Graaf, R [1 ]
Bijl, RV [1 ]
Smith, F [1 ]
Vollebergh, WAM [1 ]
Spijker, J [1 ]
机构
[1] Netherlands Inst Mental Hlth & Addict, Monitoring & Epidemiol Dept, NL-3500 AS Utrecht, Netherlands
来源
AMERICAN JOURNAL OF PSYCHIATRY | 2002年 / 159卷 / 04期
关键词
D O I
10.1176/appi.ajp.159.4.620
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: This study examined risk factor profiles of pure and comorbid 12-month mood, anxiety, and substance use disorder in the general population. Method: Data were derived from the Netherlands Mental Health Survey and Incidence Study, a prospective epidemiologic study in which a representative sample of 7,076 adults age 18-64 years were interviewed with the Composite international Diagnostic Interview. Logistic regression was used to compare subjects with a diagnosis of pure and comorbid disorders with non psychopathological comparison subjects and to compare subjects with comorbid disorders with those with pure disorder on sociodemographic characteristics, chronic somatic conditions, parental psychiatric history, and childhood traumas and adversities. Results: Only 39.5% of the subjects with a 12-month mood disorder, 59.3% of those with an anxiety disorder, and 75.4% of those with a substance use disorder exhibited the disorder in the pure form. Comorbid anxiety and mood disorders, the most prevalent comorbid condition, showed associations with eight of the nine sociodemographic and long-term vulnerability factors investigated; pure mood disorder and pure anxiety disorder were each linked to only about half of the factors. Female gender, younger age, lower educational level, and unemployment were associated with comorbid anxiety and mood disorders but not with pure mood disorders. The risk profiles of pure anxiety disorder and pure substance use disorder similarly diverged from those of the comorbid conditions. Conclusions: High levels of psychiatric comorbidity exist in the general population. The risk factor profiles for comorbid disorders differ considerably from those for pure disorders. Primary prevention of secondary disorders in populations with a history of a primary disorder are important for reducing psychiatric burden.
引用
收藏
页码:620 / 629
页数:10
相关论文
共 50 条
  • [1] Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders - Findings from the Netherlands Mental Health Survey and Incidence Study
    de Graaf, R
    Bijl, RV
    Spijker, J
    Beekman, ATF
    Vollebergh, WAM
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2003, 38 (01) : 1 - 11
  • [2] Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders Findings from the Netherlands Mental Health Survey and Incidence Study
    R. de Graaf
    R. V. Bijl
    J. Spijker
    A. T. F. Beekman
    W. A. M. Vollebergh
    Social Psychiatry and Psychiatric Epidemiology, 2003, 38 : 1 - 11
  • [3] Common and Unique Risk Factors and Comorbidity for 12-Month Mood and Anxiety Disorders Among Canadians
    Meng, Xiangfei
    D'Arcy, Carl
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2012, 57 (08): : 479 - 487
  • [4] Barriers to 12-month treatment of common anxiety, mood, and substance use disorders in the World Mental Health (WMH) surveys
    Viana, Maria Carmen
    Kazdin, Alan E.
    Harris, Meredith G.
    Stein, Dan J.
    Vigo, Daniel V.
    Hwang, Irving
    Manoukian, Sophie M.
    Sampson, Nancy A.
    Alonso, Jordi
    Andrade, Laura Helena
    Borges, Guilherme
    Bunting, Brendan
    Caldas-de-Almeida, Jose Miguel
    de Girolamo, Giovanni
    de Jonge, Peter
    Gureje, Oye
    Haro, Josep Maria
    Karam, Elie G.
    Kovess-Masfety, Viviane
    Moskalewicz, Jacek
    Navarro-Mateu, Fernando
    Nishi, Daisuke
    Piazza, Marina
    Posada-Villa, Jose
    Scott, Kate M.
    Vladescu, Cristian
    Wojtyniak, Bogdan
    Zarkov, Zahari
    Kessler, Ronald C.
    Kessler, Timothy
    World Mental Hlth Survey collaborators, Sergio
    INTERNATIONAL JOURNAL OF MENTAL HEALTH SYSTEMS, 2025, 19 (01):
  • [5] Rapid onset of comorbidity of common mental disorders: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS)
    de Graaf, R
    Bijl, RV
    ten Have, M
    Beekman, ATF
    Vollebergh, WAM
    ACTA PSYCHIATRICA SCANDINAVICA, 2004, 109 (01) : 55 - 63
  • [6] 12-month comorbidity patterns and risk factors in the European Study of Mental Disorders (ESEMeD/MHEDEA 2000)
    de Graaf, R
    ACTA PSYCHIATRICA SCANDINAVICA, 2004, 110 : 35 - 36
  • [7] First-incidence of DSM-IV mood, anxiety and substance use disorders and its determinants: Results from the Netherlands Mental Health Survey and Incidence Study-2
    de Graaf, Ron
    ten Have, Margreet
    Tuithof, Marlous
    van Dorsselaer, Saskia
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 149 (1-3) : 100 - 107
  • [8] The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and Well-Being
    Hall, W
    Teesson, M
    Lynskey, M
    Degenhardt, L
    ADDICTION, 1999, 94 (10) : 1541 - 1550
  • [9] Patterns and predictors of 12-month treatment of common anxiety, mood, and substance use disorders in the World Mental Health (WMH) surveys: treatment in the context of perceived need
    Stein, Dan J.
    Vigo, Daniel V.
    Harris, Meredith G.
    Kazdin, Alan E.
    Viana, Maria Carmen
    Hwang, Irving
    Kessler, Timothy L.
    Manoukian, Sophie M.
    Sampson, Nancy A.
    Alonso, Jordi
    Andrade, Laura Helena
    Benjet, Corina
    Bruffaerts, Ronny
    Bunting, Brendan
    Cardoso, Graca
    Chardoul, Stephanie
    de Girolamo, Giovanni
    de Jonge, Peter
    Gureje, Oye
    Haro, Josep Maria
    Karam, Elie G.
    Kovess-Masfety, Viviane
    Moskalewicz, Jacek
    Navarro-Mateu, Fernando
    Nishi, Daisuke
    Posada-Villa, Jose
    Scott, Kate
    Stagnaro, Juan Carlos
    Vladescu, Cristian
    Wciorka, Jacek
    Zarkov, Zahari
    Kessler, Ronald C.
    Aguilar-Gaxiola, Sergio
    Al-Hamzawi, Ali
    Altwaijri, Yasmin A.
    Atwoli, Lukoye
    Borges, Guilherme
    Bromet, Evelyn J.
    Caldas-de-Almeida, Jose Miguel
    Cia, Alfredo H.
    Degenhardt, Louisa
    de Guzman, Ma. Lourdes Rosanna E.
    Hinkov, Hristo
    Hu, Chi-yi
    Karam, Aimee Nasser
    Karam, Georges
    Kawakami, Norito
    Khaled, Salma
    Kiejna, Andrzej
    Mcgrath, John J.
    INTERNATIONAL JOURNAL OF MENTAL HEALTH SYSTEMS, 2025, 19 (01):
  • [10] 12-month herbal medicine use for mental health from the National Comorbidity Survey Replication (NCS-R)
    Ravven, Simha E.
    Zimmerman, M. Bridget
    Schultz, Susan K.
    Wallace, Robert B.
    ANNALS OF CLINICAL PSYCHIATRY, 2011, 23 (02) : 83 - 94